PD-1 Inhibitors

Explore clinical trials studying PD-1 Inhibitors. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

PD-1 Inhibitors trial results

Recruiting

Electro-Acupuncture in Lung cancER : EALER Study

NCT07337096

Conditions: Accupuncture, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China

Jiangsu Provincial Hospital of Chinese Medicine Nanjing, Jiangsu, China

View Trial Details

Recruiting

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

NCT07359040

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

NCT07239661

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

NCT07086300

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

NCT06708650

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Guiping People's Hospital Guiping, Guangxi, China

View Trial Details

Completed

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

NCT06631326

Conditions: Adenocarcinoma, BCLC Stage C Hepatocellular Carcinoma, Carcinoma, +13 more
Locations: The first hospital of China medical university Shenyang, Liaoning, China

View Trial Details

Completed

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

NCT06195254

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Junjie Wang Beijing, Beijing Municipality, China

View Trial Details

PD-1 Inhibitors

PD-1 Inhibitors trial results

Electro-Acupuncture in Lung cancER : EALER Study

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

Related conditions